These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common. Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462 [TBL] [Abstract][Full Text] [Related]
6. Enterobacteriaceae that produce extended-spectrum β-lactamases and AmpC β-lactamases in the community: the tip of the iceberg? Pitout JD Curr Pharm Des; 2013; 19(2):257-63. PubMed ID: 22934977 [TBL] [Abstract][Full Text] [Related]
7. Oral treatment options for patients with urinary tract infections caused by extended spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae. Raja NS J Infect Public Health; 2019; 12(6):843-846. PubMed ID: 31176606 [TBL] [Abstract][Full Text] [Related]
10. Inventory of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in France as Assessed by a Multicenter Study. Robin F; Beyrouthy R; Bonacorsi S; Aissa N; Bret L; Brieu N; Cattoir V; Chapuis A; Chardon H; Degand N; Doucet-Populaire F; Dubois V; Fortineau N; Grillon A; Lanotte P; Leyssene D; Patry I; Podglajen I; Recule C; Ros A; Colomb-Cotinat M; Ponties V; Ploy MC; Bonnet R Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956424 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of empirical therapy with non-carbapenems for urinary tract infections with extended-spectrum beta-lactamase-producing Enterobacteriaceae. Asakura T; Ikeda M; Nakamura A; Kodera S Int J Infect Dis; 2014 Dec; 29():91-5. PubMed ID: 25461239 [TBL] [Abstract][Full Text] [Related]
12. Should we consider faecal colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae in empirical therapy of community-onset sepsis? Stupica D; Lusa L; Klevišar MN; Terzić S; Pirš M; Premru MM; Strle F Int J Antimicrob Agents; 2017 Oct; 50(4):564-571. PubMed ID: 28711676 [TBL] [Abstract][Full Text] [Related]
13. Epidemiology of Enterobacteriaceae producing CTX-M type extended spectrum β-lactamase (ESBL). Lahlaoui H; Ben Haj Khalifa A; Ben Moussa M Med Mal Infect; 2014 Sep; 44(9):400-4. PubMed ID: 25234380 [TBL] [Abstract][Full Text] [Related]
14. Characterization of CTX-M type ESBL-producing Enterobacteriaceae isolated from asymptomatic healthy individuals who live in a community of the Okinawa prefecture, Japan. Higa S; Sarassari R; Hamamoto K; Yakabi Y; Higa K; Koja Y; Hirai I J Infect Chemother; 2019 Apr; 25(4):314-317. PubMed ID: 30292768 [TBL] [Abstract][Full Text] [Related]
15. Treatment of extended-spectrum β-lactamases infections: what is the current role of new β-lactams/β-lactamase inhibitors? Bassetti M; Giacobbe DR; Robba C; Pelosi P; Vena A Curr Opin Infect Dis; 2020 Dec; 33(6):474-481. PubMed ID: 33060469 [TBL] [Abstract][Full Text] [Related]
16. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years. Aris P; Boroumand MA; Rahbar M; Douraghi M Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348 [TBL] [Abstract][Full Text] [Related]
17. Four-year epidemiological study of extended-spectrum β-lactamase-producing Enterobacteriaceae in a French teaching hospital. Gibold L; Robin F; Tan RN; Delmas J; Bonnet R Clin Microbiol Infect; 2014 Jan; 20(1):O20-6. PubMed ID: 23927626 [TBL] [Abstract][Full Text] [Related]
18. Management of infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae: current evidence and future prospects. Sheu CC; Lin SY; Chang YT; Lee CY; Chen YH; Hsueh PR Expert Rev Anti Infect Ther; 2018 Mar; 16(3):205-218. PubMed ID: 29402125 [TBL] [Abstract][Full Text] [Related]
19. Extended spectrum β-lactamase producing enterobacteriaceae: carbapenem sparing options. Aslan AT; Akova M Expert Rev Anti Infect Ther; 2019 Dec; 17(12):969-981. PubMed ID: 31722185 [No Abstract] [Full Text] [Related]
20. Intestinal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae at admission in a Portuguese hospital. Aires-de-Sousa M; Lopes E; Gonçalves ML; Pereira AL; Machado E Costa A; de Lencastre H; Poirel L Eur J Clin Microbiol Infect Dis; 2020 Apr; 39(4):783-790. PubMed ID: 31873863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]